Beam Therapeutics Inc. · BMV:BEAM

Beam Therapeutics Inc. financial statements

Beam Therapeutics Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue139.7M63.5M377.7M60.9M51.8M24.0K18.0K0
Cost of revenue22.3M367.6M437.4M311.6M232.1M103.2M54.6M33.9M11.0K
Gross profit117.4M-304.0M377.7M-250.7M-180.3M-103.2M-54.6M-33.9M-11.0K
Research and development409.6M367.6M437.4M311.6M387.1M103.2M54.6M33.9M5.86M
Selling, general and administrative113.8M111.5M116.8M87.8M57.2M29.6M20.6M11.9M2.02M
Operating income-383.7M-415.6M-176.5M-338.5M-392.5M-132.8M-75.2M-45.7M-8.60M
Depreciation and amortization22.3M21.9M20.0M14.1M7.45M4.74M3.50M650.0K11.0K
EBITDA-361.4M-393.6M-156.5M-324.3M-385.0M-128.0M-71.7M-45.1M-8.59M
Interest expense43.7M49.1M46.7M15.3M9.00K1.57M187.0K00
Income before tax-80.0M-376.7M-131.2M-260.2M-370.6M-194.6M-78.3M-116.7M-8.73M
Income tax039.0K1.37M3.41M000-71.0M500.0K
Net income-80.0M-376.7M-132.5M-289.1M-370.6M-194.6M-78.3M-115.3M-8.73M
Earnings per share, basic-0.81-4.58-1.72-4.13-5.77-4.19-14.05-3.28-0.67
Earnings per share, diluted-0.81-4.58-1.72-4.13-5.77-4.19-14.05

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents294.9M282.0M435.9M232.8M560.0M162.2M37.2M146.4M1.90M
Short-term investments950.3M568.8M754.0M845.4M405.7M137.5M54.6M
Receivables0300.0M0
Inventory-607.4M
Current assets1.27B878.1M1.21B1.09B1.27B308.3M94.5M148.3M2.04M
Property, plant and equipment104.5M111.4M125.0M115.6M84.3M38.5M24.3M16.9M
Total assets1.48B1.10B1.46B1.34B1.47B451.7M156.1M167.0M2.40M
Accounts payable10.2M3.87M1.62M9.03M7.47M6.31M7.85M7.35M726.0K
Current liabilities96.9M182.1M205.6M223.6M213.4M102.3M29.1M25.6M6.57M
Long-term debt3.01M5.29M4.41M
Total debt293.9M161.4M172.7M179.0M147.6M107.6M31.2M1.01M
Total liabilities242.8M370.3M478.4M608.2M647.7M206.1M55.2M33.0M6.58M
Shareholders' equity1.24B733.5M981.3M733.5M826.7M245.6M-201.1M134.0M-4.18M
Shares outstanding101.7M83.6M81.6M71.3M68.4M57.3M7.33M35.1M13.0M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations-345.1M-347.2M-149.2M22.5M-66.3M-95.7M-72.0M-20.3M-2.71M
Capital spending-14.9M-8.95M-33.7M-49.0M-46.8M-16.4M-12.5M-13.1M-346.0K
Free cash flow-360.0M-356.2M-182.9M-26.4M-113.1M-112.1M-84.5M-33.4M-3.05M
Cash from investing-121.4M185.0M71.8M-461.3M-294.1M-100.1M-66.7M-13.4M-346.0K
Cash from financing478.0M7.74M276.4M111.6M756.1M322.3M41.3M179.7M4.98M
Dividends paid-12.7M
Share buybacks758.3M-25.2M
Change in cash11.5M-154.5M199.1M-327.2M395.7M126.5M-97.4M146.0M1.93M